Cutaneous Small-Vessel Vasculitis following Non-Vitamin K Antagonist Oral Anticoagulants (NOACs), Warfarin, or Allopurinol Use in Patients with Atrial Fibrillation: A Descriptive Analysis

Project Title Cutaneous Small-Vessel Vasculitis following Non-Vitamin K Antagonist Oral Anticoagulants (NOACs), Warfarin, or Allopurinol Use in Patients with Atrial Fibrillation: A Descriptive Analysis
Description

The purpose of this request was to calculate the number of treated patients and time to treatment among patients exposed to either non‐vitamin K antagonist oral anticoagulants (NOACs), warfarin, or allopurinol who had a prior diagnosis of atrial fibrillation in the Sentinel Distributed Database (SDD). The outcomes of interest were cutaneous small‐vessel vasculitis (CSVV) followed by a treatment of prednisone or prednisolone or steroid medication within 90 days.

Link
Published Date
Tuesday, September 15, 2020
Category
Modular Programs and Summary Tables
Scroll to Top